期刊文献+

晚期肺癌合并糖尿病患者临床综合治疗用药分析 被引量:1

Analysis of Drug Use in Clinical Comprehensive Therapy for Advanced Lung Cancer Patients with Diabetes Mellitus
原文传递
导出
摘要 目的:探讨临床药师对肿瘤患者的药学监护要点。方法:结合1例晚期肺癌合并糖尿病患者的用药情况,提出临床药师监护要点。结果:按照临床药师提出的意见调整用药后,患者血糖控制较稳定,症状逐步缓解,骨痛控制良好。结论:临床药师需结合患者病情,综合分析用药情况,提出个体化用药指导。 OBJECTIVE:To discuss the key points of pharmaceutical care for patients with tumor.METHODS:Key points of pharmaceutical care were put forward according to 1 case of advanced lung cancer with diabetes mellitus.RESULTS:After adjusting the medication according to clinical pharmacists'advice,the level of blood glucose remained stable and symptom were relieved regularly.Ache of bone was controlled.CONCLUSION:Clinical pharmacist should supply individualized drug therapy by analyzing drug use comprehensively based on the condition of patients.
出处 《中国药房》 CAS CSCD 北大核心 2010年第38期3646-3648,共3页 China Pharmacy
关键词 临床药师 用药分析 药学监护 肺癌 糖尿病 Clinical pharmacist Analysis of drug use Pharmaceutical care Lung cancer Diabetes mellitus
  • 相关文献

参考文献6

  • 1Stafford JM, Elasy T. Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes[J]. Vasc Health Risk Manag, 2007,3(4) : 503. 被引量:1
  • 2Schnell O, Mertes G, Standl E, et al.Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy[J].Diabetes Obes Metab, 2007,9 (6):853. 被引量:1
  • 3Lasserson DS, Glasziou P, Perera R, et al. Optimal insulin regimens in type 2 diabetes mellitus: systematic review and Meta-analyses[J]. Diabetologia, 2009,52 (10) : 1 990. 被引量:1
  • 4孙忠实主编,“百万药师关爱工程”系列教材编委会编著..临床药理学[M].北京:北京科学技术出版社,2005:560.
  • 5刘治军,傅得兴,孙春华,迟家敏,张亚同.体内药物相互作用研究进展[J].药物不良反应杂志,2006,8(1):33-38. 被引量:63
  • 6Pelkonen O, Turpeinen M, Hakkola J, et al. Inhibition and induction of human cytochrome P450 enzymes : current status[J]. Arch Toxicol, 2008,82 (10) : 667. 被引量:1

二级参考文献25

  • 1靳婷,李玉衡,刘媛,徐罡,陈淑玉,艾维颖,高军.暗访京城50家医院医师安全用药水平状况——47家医院医师未识出“问题处方”令人震惊[J].首都医药,2006,13(1):4-10. 被引量:3
  • 2千叶宽 小林力オル.代谢过程[J].药局(日),1998,49(1):53-56. 被引量:7
  • 3Jankel, CA; Speedie, SM. Detecting drug interactions: a review of the literature[J]. DICP, 1990, 24(10): 982. 被引量:1
  • 4Prince, BS; Goetz, CM; Rihn, T L; et al. Drug-related emergency department visits and hospital admissions [J].Am J Hosp Pharm, 1992, 49(7): 1696. 被引量:1
  • 5Zhan C, Correa-de-Araujo R. Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drugdisease combinations[J].J Am Geriatr Soc. 2005, 53 (2):262. 被引量:1
  • 6Courtman B J; Stallings, SB. Characterization of drug-related problems in elderly patients on admission to a medical ward[J]. Can J Hosp Pharm, 1995, 48(3): 161. 被引量:1
  • 7Monahan BP, Ferguson CL, Killeavy ES, et al. Torsades de pointes occurring in association with terfenadine use [J].JAMA, 1990, 264(21):2788. 被引量:1
  • 8周勇摘.无镇静作用的抗组胺药是否会导致室性心率不齐[J].国外医学:药学分册,1999,26(5):311-311. 被引量:3
  • 9Watabe T. Strategic proposals for predicting drug-drug interactions during new drug development: based on sixteen deaths caused by interactions of the new antiviral sorivu dine with 5-fluorouracil prodrugs[J]. J Toxicol Sci, 1996,21(5):299. 被引量:1
  • 10Okuda H, Nishiyama T, Ogura K, et al.Lethal drug interactions of sorivudine, a new antiviml drug, with oral 5-fluorouracil prodrugs[J]. Drug Metab Dispos, 1997, 25(5):270. 被引量:1

共引文献62

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部